News
Why True Health Foods Need Evidence, Not Fashion

Why True Health Foods Need Evidence, Not Fashion

Functional foods have entered the mainstream, but adding a recognised ingredient is not the same as creating a credible product. A cardiologist argues that the category’s next phase will be won on scientific rationale, dose and honest communication, not on the length...

read more
Weekly News Roundup | 03 August 2026

Weekly News Roundup | 03 August 2026

Life science news 3 August 2026: argenx pays $2.2 billion for what it calls a first-in-class anti-CD122 antibody, Johnson & Johnson strikes agreements worth up to $3.5 billion with in vivo CAR-T developer Sail Biomedicines, and GSK launches a £1.9 billion savings...

read more
Weekly News Roundup | 30 March 2026

Weekly News Roundup | 30 March 2026

Life science news 30 March 2026: Three blockbuster deals, two FDA accelerated approvals and intensifying GLP-1 competition headline a busy week for pharma and biotech. Merck agreed on 25 March to acquire Terns Pharmaceuticals for $6.7 billion, gaining access to...

read more
Weekly News Roundup | 23 March 2026

Weekly News Roundup | 23 March 2026

Your essential life science news  23 March 2026 digest: the past week’s biggest stories in pharma, biotech and healthcare. The FDA approved Johnson and Johnson's once-daily psoriasis pill ICOTYDE (icotrokinra) on 18 March, making it the world's first oral peptide to...

read more
Power Outages as a Clinical Risk Multiplier in Healthcare

Power Outages as a Clinical Risk Multiplier in Healthcare

Electricity as a Hidden Dependency in Healthcare Reliable electricity is a foundational requirement for modern healthcare systems. From acute hospital care to long-term residential facilities and home-based treatment, uninterrupted power underpins virtually every...

read more
Weekly News Roundup | 16 March 2026

Weekly News Roundup | 16 March 2026

Your essential life science news digest: the past week's biggest stories in pharma, biotech and healthcare. 👇 This week's life science news was defined by regulatory uncertainty and clinical momentum. A landmark FDA leadership departure sent rare disease stocks...

read more